表紙
市場調查報告書

新型冠狀病毒 (COVID-19) 更新:分子診斷、免疫測定、疫苗、遠距醫療及其他領域

Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas

出版商 Kalorama Information 商品編碼 931282
出版日期 內容資訊 英文 105 Pages
商品交期: 最快1-2個工作天內
價格
新型冠狀病毒 (COVID-19) 更新:分子診斷、免疫測定、疫苗、遠距醫療及其他領域 Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
出版日期: 2020年04月07日內容資訊: 英文 105 Pages
簡介

多年來持續在分子診斷、免疫測定、疫苗、遠距醫療等領域進行調查,目前成為新型冠狀病毒 (COVID-19) 危機當中所面臨的挑戰。

該報告分析新型冠狀病毒 (COVID-19) 流行病中的快速事件,以及其傾向及企業公告。

在特定部分討論最重要的市場變化。

  • 分子診斷:必須特別注意的是,分子檢查的檢測概念起源於愛滋病危機期間,此後被應用於許多新興和成熟的傳染病類別。COVID-19見證體外診斷(IVD)業界盡了最大的努力,例如快速測試RT-PCR測試,POC定點照護方案,症狀測試,高通量系統以及急需的試劑量產。
  • 免疫測定:因為非常需要抗體測試,免疫測定從來沒有像現在這樣受到全世界的關注。隨之而來的是對廣泛人群準確性的關注,以及對開發時間的更多瞭解。現在正在開發免疫測定法。我們追蹤到目前為止的努力,進行解說的部分包括:測試分子診斷法迄今為止主導的威脅所扮演的作用。
  • 疫苗:我們著眼於開發疫苗,並且與其他流行病中發現的疫苗與製造程序奮鬥。介紹開發疫苗的公司。
  • 其他傳統的IVD:在全球許多醫院都封院的狀態中,標準體外診斷檢查的影響以及可預想的未來將會變成什麼狀態?
  • 遠距患者診斷:雖然已經跟上醫療趨勢,遠距患者診療及遠距醫療在社交距離政策及放緩的HIPAA規則下,有了轉變。

由於形勢瞬息萬變,本報告並不尋求提供以數據為依據的市場評估,但確實提供可以幫助客戶制定模型的分析師評論。市場預測的一部份為判斷潛在的市場影響提供基礎。

沒有一家公司擁有針對COVID-19的解決方案。多家公司擁有針對一個問題或部分問題的解決方案,這些公司正在合作建立實力並提供產品。 報告將提及一部分的公司,如下:

提及企業

  • Abbott
  • Amaro Lab of the University of California (UC), San Diego
  • Avellino Lab USA
  • BGI
  • BioFire
  • Biofourmis
  • Boston Scientific
  • Bruker
  • Cepheid
  • Clover
  • Credo Diagnostics Biomedical
  • Diagnostics for the Real World
  • DiaSorin Molecular
  • Dynavax
  • Emerald Organic
  • EpiGentek
  • Fluxergy
  • GE Healthcare
  • Generation Bio
  • Genetic Signatures
  • GenMark Diagnostics
  • Gilead Science
  • Green Cross
  • Hackensack Meridian Health, Center for Discovery and Innovation's (CDI)
  • Henry Schein
  • HiberGene Diagnostics
  • Hologic
  • JLK Inspection
  • Johnson & Johnson (J&J)
  • Kleo
  • Laboratory Corporation of America (LabCorp)
  • Luminex
  • Medtronic
  • Mesa Biotech
  • Mobidiag
  • Molbio Diagnostics
  • NeuMoDx
  • PerkinElmer
  • Persivia
  • Philips Medical
  • Primer Design
  • Qiagen
  • QuantuMDx
  • Quest
  • Quidel
  • Roche
  • Surgisphere
  • T2 Biosytems
  • Thermo Fisher
  • ThermoGenesis
  • Todos Medical
  • Vir
  • Wadsworth Center, New York State Department of Health
  • Xencor
目錄
Product Code: 20-054

For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic.

Particular sections address the most important market changes:

  • Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time of the AIDS crisis, and has since been brought to bear on a number of emerging and mature infectious disease categories. COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
  • Immunoassays: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics.
  • Vaccines: We look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics. Companies developing vaccines are featured.
  • Other Traditional IVDs: With many hospitals shut down across the globe, what is the impact and expected future of standard in vitro diagnostic testing? - from company statements made both publicly and directly to Kalorama.
  • Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. But will market players be crowded out by traditional phone and web video companies?

This report does not seek to provide a data-driven market assessment due to the rapidly-changing situation, but does provide analyst commentary that may assist customers needing to work out models. Some of Kalorama Information's market estimates provide foundational bases on which to judge potential market impact. Commentary and analysis from Kalorama authors who have studied markets in some cases for decades add understanding to the current, often chaotic, market atmosphere. Further publications and surveys from Kalorama Information will provide additional market impact data.

No one company has the solution to COVID-19. Multiple companies have solutions to one problem or part of the solution, and companies are partnering to build strength and distribute products. As part of its coverage, the report mentions the following companies:

  • Abbott
  • Amaro Lab of the University of California (UC), San Diego
  • Avellino Lab USA
  • BGI
  • BioFire
  • Biofourmis
  • Boston Scientific
  • Bruker
  • Cepheid
  • Clover
  • Credo Diagnostics Biomedical
  • Diagnostics for the Real World
  • DiaSorin Molecular
  • Dynavax
  • Emerald Organic
  • EpiGentek
  • Fluxergy
  • GE Healthcare
  • Generation Bio
  • Genetic Signatures
  • GenMark Diagnostics
  • Gilead Science
  • Green Cross
  • Hackensack Meridian Health, Center for Discovery and Innovation's (CDI)
  • Henry Schein
  • HiberGene Diagnostics
  • Hologic
  • JLK Inspection
  • Johnson & Johnson (J&J)
  • Kleo
  • Laboratory Corporation of America (LabCorp)
  • Luminex
  • Medtronic
  • Mesa Biotech
  • Mobidiag
  • Molbio Diagnostics
  • NeuMoDx
  • PerkinElmer
  • Persivia
  • Philips Medical
  • Primer Design
  • Qiagen
  • QuantuMDx
  • Quest
  • Quidel
  • Roche
  • Surgisphere
  • T2 Biosytems
  • Thermo Fisher
  • ThermoGenesis
  • Todos Medical
  • Vir
  • Wadsworth Center, New York State Department of Health
  • Xencor